406
Views
1
CrossRef citations to date
0
Altmetric
News, Policy & Profiles

Human Vaccines & Immunotherapeutics: News

Pages 1427-1430 | Received 22 May 2014, Accepted 22 May 2014, Published online: 01 Jun 2014
 

Abstract

Sanofi Pasteur shows efficacy of its dengue vaccine in phase 3

New glioblastoma vaccine: Safe and immunogenic in phase 1

FDA approves sublingual hay fever immunotherapeutic

Combining the cancer vaccine DPX-Survivac with immune modulators

Two Meningococcal B vaccines receive FDA "Breakthrough Therapy" designation

MERS vaccine is technically feasible, but is it commerically feasible?

Stemline’s synthetic multi-peptide cancer vaccine enters Phase 2

Evolution of whooping cough bacterium may reduce vaccine effectiveness

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.